Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases

Immune checkpoint inhibitors (ICIs) have become the mainstay treatment for non-small cell lung cancer (NSCLC). However, there is a lack of studies assessing ICIs as subsequent treatment in older adults with NSCLC and brain metastasis (BM). This retrospective cohort study compared the real-world surv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Translational lung cancer research 2024-07, Vol.13 (7), p.1620-1634
Hauptverfasser:	Mahashabde, Ruchira V, Bhatti, Sajjad A, Martin, Bradley C, Painter, Jacob T, Rodriguez, Analiz, Ying, Jun, Li, Chenghui
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!